Matrix Metalloproteinase-2 and -9 Levels in Obese Patients

REFERENCES

• Ailhaud G., Grimaldi P., Ne'grel R. Cellular and molecular aspects of adipose tissue development. Annual Review of Nutrition 1992; 12: 207–233
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Screening for diabetes (Position Statement). Diabetes Care 2001; 24: S21–S24
   Google Scholar
• Bouloumié A., Sengenès C., Portolan G., Galitzky J., Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001; 50: 2080–2086
   PubMed Web of Science ®Google Scholar
• Brown L. M., Fox H. L., Hazen S. A., LaNoue K. F., Rannels S. R., Lynch C. J. Role of the matrix in MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. American Journal of Physiology 1997; 272: C937–C949
   PubMed Web of Science ®Google Scholar
• Cicero A. F., Derosa G., Manca M., Bove M., Borghi C., Gaddi A. V. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium 2007; 14: 193–198
   PubMed Web of Science ®Google Scholar
• Crandall D. L., Hausman G. J., Kral J. G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997; 4: 211–232
   PubMed Web of Science ®Google Scholar
• Death A. K., Fisher E. J., McGrath K. C., Yue D. K. High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes. Atherosclerosis 2003; 168: 263–269
   PubMed Web of Science ®Google Scholar
• Derosa G., Avanzini M. A., Geroldi D., Fogari R., Lorini R., De Silvestri A., Tinelli C., Rondini G., d'Annunzio G. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes. Diabetes Care 2004; 27: 273–274
   PubMed Web of Science ®Google Scholar
• Derosa G., Avanzini M. A., Geroldi D., Fogari R., Lorini R., De Silvestri A., Tinelli C., Rondini G., d'Annunzio G. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. Diabetes Research and Clinical Practice 2005; 70: 119–125
   PubMed Web of Science ®Google Scholar
• Derosa G., D'Angelo A., Ciccarelli L., Piccinni M. N., Pricolo F., Salvadeo S., Montagna L., Gravina A., Ferrari I., Galli S., Paniga S., Tinelli C., Cicero A. F. Matrix Metalloproteinase-2, -9 and tissue inhibitor metalloproteinase-1 in patients with hypertension. Endothelium 2006; 13: 227–231
   PubMed Web of Science ®Google Scholar
• Derosa G., D'Angelo A., Scalise F., Avanzini M. A., Tinelli C., Peros E., Fogari E., Cicero A. F. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary sindrome. Heart and Vessels 2007a; 22: 361–370
   PubMed Web of Science ®Google Scholar
• Derosa G., D'Angelo A., Tinelli C., Devangelio E., Consoli A., Miccoli R., Penno G., Del Prato S., Paniga S., Cicero A. F. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes and Metabolism 2007b; 33: 129–134
   PubMed Web of Science ®Google Scholar
• Derosa G., Cicero A. F., Scalise F., Avanzini M. A., Tinelli C., Peros E., Fogari E., D'Angelo A. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months. Endothelium 2007c; 14: 175–183
   PubMed Web of Science ®Google Scholar
• Derosa G., Cicero A. F., Scalise F., Avanzini M. A., Tinelli C., Piccinni M. N., Peros E., Geroldi D., Fogari E., D'Angelo A. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes. Endothelium 2007d; 14: 45–51
   PubMed Web of Science ®Google Scholar
• Dollery C. M., Libby P. Atherosclerosis and proteinase activation. Cardiovascular Research 2006; 69: 625–635
   PubMed Web of Science ®Google Scholar
• European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabetic Medicine 1999; 16: 716–730
   PubMed Web of Science ®Google Scholar
• Florys B., Gowióska B., Urban M., Peczyóska J. Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes. Endokrynologia Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego 2006; 12: 184–189
   PubMedGoogle Scholar
• Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Fujimoto N., Mouri N., Iwata K., Ohuchi E., Okada Y., Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clinica Chimica Acta 1993; 221: 91–103
   PubMed Web of Science ®Google Scholar
• Fujimoto N., Hosokawa N., Iwata K., Shinya T., Okada Y., Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clinica Chimica Acta 1994; 231: 79–88
   PubMed Web of Science ®Google Scholar
• Glowin'ska-Olszewska B., Urban M. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism Clinical and Experimental 2007; 56: 799–805
   PubMed Web of Science ®Google Scholar
• Havel R. J., Edr H. A., Bragdon J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 1955; 34: 1345–1353
   PubMed Web of Science ®Google Scholar
• Heding L. G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–266
   PubMed Web of Science ®Google Scholar
• Hirsch J., Batchelor B. Adipose tissue cellularity in human obesity. Clinics in Endocrinology and Metabolism 1976; 5: 299–311
   PubMedGoogle Scholar
• Kahn B. B., Flier J. S. Obesity and insulin resistance. Journal of Clinical Investigation 2000; 106: 473–481
   PubMed Web of Science ®Google Scholar
• Klose S., Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II). Journal of Clinical Chemistry and Clinical Biochemistry 1978; 15: 121–130
   Google Scholar
• Laimer M., Kaser S., Kranebitter M., Sandhofer A., Mühlmann G., Schwelberger H., Weiss H., Patsch J. R., Ebenbichler C. F. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker metalloproteinase-9 in middle aged morbidly obese women. International Journal of Obesity 2005; 29: 498–501
   PubMed Web of Science ®Google Scholar
• Lijnen H. R. Plasmin and matrix metalloproteinases in vascular remodelling. Thrombosis and Haemostasis 2001; 86: 324–333
   PubMed Web of Science ®Google Scholar
• Lijnen H. R., Maquoi E., Demeulemeester D., Van Hoef B., Collen D. Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thrombosis and Haemostasis 2002; 88: 345–353
   PubMed Web of Science ®Google Scholar
• Lijnen H. R., Maquoi E., Holvoet P., Mertens A., Lupu F., Morange P., Alessi M. C., Juhan-Vague I. Adipose tissue expression of gelatinases in mouse models of obesity. Thrombosis and Haemostasis 2001; 85: 1111–1116
   PubMed Web of Science ®Google Scholar
• Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Maxwell P. R., Timms P. M., Chandran S., Gordon D. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. Diabetic Medicine 2001; 18: 777–780
   PubMed Web of Science ®Google Scholar
• Roberts C. K., Won D., Pruthi S., Kurtovic S., Sindhu R. K., Vaziri N. D., Barnard R. J. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. Journal of Applied Physiology 2006; 100: 1657–1665
   PubMed Web of Science ®Google Scholar
• Scanu A. M., Scandian L. Lipoprotein (a): structure, biology and clinical relevance. Advances in Internal Medicine 1991; 36: 249–270
   PubMedGoogle Scholar
• Sluijter J. P., de Kleijn D. P., Pasterkamp G. Vascular remodeling and protease inhibition-bench to bedside. Cardiovascular Research 2006; 69: 595–603
   PubMed Web of Science ®Google Scholar
• Stevens J., Cai J., Pamuk E. R., Williamson D. E., Thun M. J., Wood J. L. The effect of age on the association between body-mass index and mortality. New England Journal of Medicine 1998; 338: 1–7
   PubMed Web of Science ®Google Scholar
• Uemura S., Matsushita H., Li W., Glassford A. J., Asagami T., Lee K. H., Harrison D. G., Tsao P. S. Diabetes mellitus enhances vascular matrix metalloproteinase activity: Role of oxidative stress. Circulation Research 2001; 88: 1291–1298
   PubMed Web of Science ®Google Scholar
• Uterman G., Weber W. Protein composition of lipoprotein (a). Journal of Clinical Investigation 1987; 80: 458–465
   PubMed Web of Science ®Google Scholar
• Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circulation Research 2003; 92: 827–839
   PubMed Web of Science ®Google Scholar
• Wahlefeld A. W. Triglycerides determination after enzymatic hydrolysis. Methods of Enzymatic Analysis, 2nd English edition, H. U. Bermeyer. Academic Press, New York 1974; 18–31
   Google Scholar
• World Health Organization. Obesity: Preventing and Managing the Global Epidemic. WHO, Geneva 1997, Report of WHO Consultation on Obesity
   Google Scholar